MedPath

Comparing the effect of methylphenidate and modafinil in the reduction of crystal withdrawal symptoms and craving

Not Applicable
Conditions
Methamphetamine Dependency.
Mental and behavioural disorders due to use of other stimulants, including caffeine
Registration Number
IRCT2016022025160N2
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
60
Inclusion Criteria

Patients' age should be between 18 to 50 years; Patients should fill the informed consent form; Methamphetamine is the main substance of abuse.

Exclusion criteria:
Patients unwilling to participate at beginning or during the study; Methamphetamine is not the main substance of abuse.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Craving. Timepoint: daily for 2 weeks. Method of measurement: questionnaire and interview.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath